SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: Don Carson who wrote (68)12/1/1998 6:46:00 PM
From: William Marsh  Read Replies (1) | Respond to of 236
 
Nesbitt traded over 300,000 shares of SSB today with itself. It was both buyer and seller - which I guess accounts for why volume is 15 times normal with little change in price. With the positive news release, you'd think you'd see more of a rise. Other biotechs double or triple price on release of more speculative news that todays from SSB. Sometimes it seems SSB could find the cure for death and its price still wouldn't move.



To: Don Carson who wrote (68)12/1/1998 6:50:00 PM
From: Don Carson  Respond to of 236
 
Nesbitt moved a Block today? Company comes out with some news and it goes up 3 tiny ones. The news could only be understood by a doctor. Here lies the problem, the company needs a promoter that speaks in the understandable terms. Someday this will be a $ 25.00 stock. Just my opinion based on this horse having the fluffiest tale.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News